Elias Hellou

Interventional cardiologist / Cardiologist
Mayo Clinic - Rochester, United States of America

Latest contributions

The impact of paravalvular leak, permanent pacemaker implantation and the planning for reinterventions on lifetime management in TAVI patients

22 May 2025 – From EuroPCR 2025

How do paravalvular leak, pacemaker implantation and reintervention planning shape lifetime outcomes in TAVI patients?

This session examines these crucial aspects through the case of a 77-year-old male with bicuspid aortic valve stenosis, HFpEF and multiple comorbidities, including diabetes, obesity and sleep apnoea.

Follow the discussion to understand...

The impact of paravalvular leak, permanent pacemaker implantation and the planning for reinterventions on lifetime management in TAVI patients

PCI for complex calcific coronary artery disease - LIVE Case

22 May 2025 – From EuroPCR 2025

An 87-year-old female patient, at high bleeding risk and with preserved LV function, presented 2 months ago with an inferior STEMI and multivessel disease. She initially underwent RCA PCI followed by staged LCx PCI. She was now referred for PCI of a long, heavily calcified lesion...

PCI for complex calcific coronary artery disease - LIVE Case

TEER for primary mitral regurgitation - LIVE case

15 May 2024 – From EuroPCR 2024

A 76-year-old male, with previous CABG in 2015, hypertension, diabetes, and pulmonary hypertension (WHO2), presented with severe symptomatic primary MR (P3 flail).
The operators implanted 1 MitraClip (XTW) step-by-step, from the transseptal puncture to the closure, guided by TEE echo and under general anaesthesia, via the venous...

Mitral TEER

TAVI in TAVI - LIVE case

14 May 2024 – From EuroPCR 2024

A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...

TAVI for degenerated aortic bioprosthesis

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

14 May 2024 – From EuroPCR 2024

Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...

Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems

Rapid-fire - Challenging TAVI procedures - Part 3

20 Nov 2023 – From PCR London Valves 2023

Innovations in simulation-based training, procedural planning, monitoring and robotic PCI

17 May 2022 – From EuroPCR 2022

In this session, find out more about telemedicine, mixed reality technology in CTO proctoring, new-human grade simulator for ViV procedure planning, distance proctoring for transseptal TMVR, stent positioning assistance system, and robotic PCI.

Innovations in simulation-based training, procedural planning, monitoring and robotic PCI